摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-[苯基-(1,3-噻唑-2-基氨基)甲基]喹啉-8-醇 | 73855-38-6

中文名称
7-[苯基-(1,3-噻唑-2-基氨基)甲基]喹啉-8-醇
中文别名
——
英文名称
7-(α-thiazol-2-ylamino-benzyl)-quinolin-8-ol
英文别名
7-(α-Thiazol-2-ylamino-benzyl)-chinolin-8-ol;7-(alpha-2-Thiazolylaminobenzyl)-8-quinolinol;7-[phenyl-(1,3-thiazol-2-ylamino)methyl]quinolin-8-ol
7-[苯基-(1,3-噻唑-2-基氨基)甲基]喹啉-8-醇化学式
CAS
73855-38-6
化学式
C19H15N3OS
mdl
——
分子量
333.414
InChiKey
NQYFDGQDVDDGGJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    573.0±60.0 °C(Predicted)
  • 密度:
    1.378±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.4
  • 重原子数:
    24
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.05
  • 拓扑面积:
    86.3
  • 氢给体数:
    2
  • 氢受体数:
    5

SDS

SDS:c784618a407710d28816003e7eee25a2
查看

反应信息

点击查看最新优质反应信息

文献信息

  • FLAVIVIRUS INHIBITORS AND METHODS FOR THEIR USE
    申请人:Padmanabhan Radhakrishnan
    公开号:US20110224207A1
    公开(公告)日:2011-09-15
    Methods of treating, preventing, and/or ameliorating a Flavivirus infection in a subject are disclosed. The methods comprise administering to the subject a therapeutically effective amount of a Flavivirus inhibitor, e.g., a Flavivirus serine protease inhibitor. These methods are useful in treating, preventing, and/or ameliorating Flavivurs infections such as, for example, West Nile Virus, Dengue Virus, and Japanese Encephalitis Virus.
  • Flavivirus Inhibitors and Methods of Their Use
    申请人:Padmanabhan Radhakrishnan
    公开号:US20140038962A1
    公开(公告)日:2014-02-06
    Methods of treating, preventing, and/or ameliorating a Flavivirus infection in a subject are disclosed. The methods comprise administering to the subject a therapeutically effective amount of a Flavivirus inhibitor, e.g., a Flavivirus serine protease inhibitor. These methods are useful in treating, preventing, and/or ameliorating Flavivirus infections such as, for example, West Nile Virus, Dengue Virus, and Japanese Encephalitis Virus.
  • US8563580B2
    申请人:——
    公开号:US8563580B2
    公开(公告)日:2013-10-22
  • US8906937B2
    申请人:——
    公开号:US8906937B2
    公开(公告)日:2014-12-09
  • [EN] METHOD FOR TREATING DRUG-RESISTANT BACTERIAL AND OTHER INFECTIONS WITH CLIOQUINOL, PHANQUINONE, AND RELATED COMPOUNDS<br/>[FR] PROCÉDÉ POUR TRAITER DES INFECTIONS BACTÉRIENNES RÉSISTANT AU MÉDICAMENT ET D'AUTRES INFECTIONS PAR DU CLIOQUINOL, DE LA PHANQUINONE ET DES COMPOSÉS APPARENTÉS
    申请人:XILINAS MICHEL E
    公开号:WO2009140215A2
    公开(公告)日:2009-11-19
    The invention relates to new uses of known chelating compounds for the treatment of bacterial in fungal infections, particularly by methicilllin-resistant and other drug-resistant strains of bacteria and fungi. One of more chelating compound is administered with or without additional antibiotic or antifungal drugs to achieve improved therapy. Preferred chelating compounds include clioquinol, 5,7-dichloro-8-hydroxy-quinaldine, phanquinone, 5,7-dichloro-8-hydroxyquinoline, 5,7- di-iodo-8-hydroxyquinoline. By chelation of specific metal ions, these compounds treat any infection by bacteria or fungi whose pathogenicity depends upon metalloenzymes that require these cations. The compounds are also effective against infections caused by extended β lactamase and metallo β lactamase producing bacterial strains. Bacteria targeted by these methods include methicillin-resistant Staphylococcus aureus, penicillin resistant or intermediate resistant Streptococcus pneumoniae and other gram positive and multiresistant gram negative species and strains.
查看更多